Novo Holdings A/S's Form 4 filing
Checkmate Pharmaceuticals, Inc. (CMPI) · filed Feb 25, 2022
- Accession no.
- 0001209191-22-013316
- Filed
- Feb 25, 2022
- Trade date
- Feb 23-25, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $23.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Novo Holdings A/SCIK 0001388325 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 23, 2022 | Common Stock | SSaleDisposed | −1,820 | $2.90 | −$5,278 | 2,168,280 | Direct | |
| Feb 24, 2022 | Common Stock | SSaleDisposed | −5,990 | $2.83 | −$16,951.7 | 2,162,290 | Direct | |
| Feb 25, 2022 | Common Stock | SSaleDisposed | −300 | $2.70 | −$810 | 2,161,990 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.